Belmar Pharma Solutions

Belmar Pharma Solutions is a leading provider of compounded medications, catering to individuals seeking the highest quality pharmaceuticals tailored to their specific needs. Established in 1985, the company has evolved from a single family-owned compounding pharmacy to a conglomerate comprising various Compounding Centers of Excellence across the United States. The company's offerings include hormone pellets and personalized, sterile, and non-sterile medications, addressing areas such as hormone health, sexual wellness, and aging-related changes. With a focus on compliance standards and utilizing FDA-approved ingredients, Belmar Pharma Solutions has positioned itself as a pioneer in the industry. The latest round of investment, a Private Equity Round investment at 01 June 2023, was secured from Capital Dynamics, reflecting the company's continued growth and appeal to investors. As a player in the Biotechnology, Education, and Pharmaceutical sectors, the expansion and diversity of its portfolio through various acquisitions such as Belmar Select Outsourcing and APS Pharmacy exhibit its commitment to meeting evolving customer needs. The company's comprehensive suite of offerings, including its patient-centric approach, positions it as a significant player in the pharmaceutical landscape. With an emphasis on addressing the specific needs of its clientele, Belmar Pharma Solutions remains at the forefront of the compounded medications industry, exemplifying its commitment to enhancing the well-being of its customers.